<overview>
The user is building "OpenCell" — an open-source whole-cell computational simulation of a living cell in Python/JAX, starting with a toy cell (~50 genes), scaling to Mycoplasma genitalium (~525 genes). The project includes a novel AI agent orchestration system with multi-model expert panels, local/cloud hybrid model routing, and formal data contracts. We completed extensive planning, brainstorming, four rounds of cross-model critique (Claude Opus 4.6, GPT-5.2, GPT-5.4, Claude Opus 4.7), and are about to incorporate the final round of findings before starting implementation. No code has been written yet.
</overview>

<history>
1. User asked about the simplest living cell and complete simulations
   - Researched: Mycoplasma genitalium (~525 genes), Karr et al. 2012 whole-cell model
   - Identified bottlenecks: data gaps, compute cost, multi-scale integration, validation, scaling

2. User proposed collaborating on building a complete cell simulation
   - Selected Python, hybrid approach (Karr-style + JAX/ML), toy cell first then M. genitalium
   - Designed 6 agent roles, 4-tier cost strategy, local/cloud hybrid model routing

3. Hardware assessment and model strategy
   - Machine: Intel i7-10700, 64GB RAM, Intel UHD 630 (no GPU), 930GB disk on E:
   - Recommended local models: Phi-4 14B, Qwen 3 14B, Gemma 4 12B via Ollama
   - Estimated cost: $310-625 hybrid local/cloud

4. Resolved architecture questions
   - Agent communication: dual-format (markdown + SBML)
   - Conflict resolution: biology-first 4-level escalation ladder
   - Data contracts: JSON Schema (CI-enforced), existing standards (SBML, SED-ML)
   - Orchestrator: two-layer (copilot-instructions.md + pipeline.py)

5. Added stretch goals and moved work to E: drive
   - E. coli model, Yeast model, Agent framework, Drug simulation as stretch goals
   - Created E:\opencell\ as primary workspace

6. First cross-model critique (Claude Opus 4.6 + GPT-5.2)
   - Major findings: need internal runtime IR, hybrid solver coupling too vague, reproducibility underspecified, FBA inside JAX is a trap, data licensing gaps
   - All findings incorporated into plan

7. User asked about LangChain/LangGraph
   - Researched current state of frameworks, determined they're wrong fit for our project
   - Added "Rejected Alternatives" section with detailed rationale

8. Incorporated first-round audit findings into plan
   - Restructured Phase 1 (14 → 22+ tasks), reordered: science first, orchestrator last
   - Added ir.py, compartments.py, checkpoint.py, manifest.py, cost_tracker.py
   - Enhanced parameter schema with DOI, uncertainty, provenance, experimental conditions
   - Updated conflict resolution, decision versioning, expert panel architecture
   - Added Mandatory Policies section (temp=0, float64, RNG, governance)
   - Added Cross-Model Audit Findings section

9. Added proactive safeguards
   - Dependency compatibility check (verify JAX/Diffrax/COBRApy on Python 3.12) — Phase 1
   - 2-model coupling benchmark (DummyProducer/Consumer) — Phase 1
   - Database access checklist moved to Phase 1 (was Phase 2 gate)

10. User shared GitHub info
    - Enterprise account: sdrona_microsoft (Microsoft managed) — NOT using this
    - Personal account: sdrona-ms — repo will be sdrona-ms/opencell (private until Phase 3)

11. Confidence assessment
    - 75% toy cell, 50% M. genitalium, 40% matching Karr 2012
    - Key bottlenecks: hybrid solver coupling, parameter gaps, stiff ODEs, no GPU
    - Database access: BRENDA (free), KEGG (free API, no redistribution), BioCyc (paid ~$100-150/yr), UniProt/GenBank (free)
    - Karr 2012 published ~1,900 parameters on GitHub — primary data source

12. BRENDA API testing
    - User registered with dronasrinivas@gmail.com
    - Account activated on web portal but SOAP API returned "account not activated" — likely propagation delay
    - Will retry later; Karr 2012 data is fallback
    - User needs to change BRENDA password (was exposed in chat)

13. Added dev blog to plan (docs/blog/ folder, MkDocs-compatible)

14. Second cross-model critique (GPT-5.4 + Claude Opus 4.7)
    - Both completed successfully
    - GPT-5.4 key findings: no identifiability/uncertainty program, validation anchored to Karr not reality, AI panels not decision-makers, no observation model, no environment/media model, no thermodynamic feasibility, need benchmark charter
    - Opus 4.7 key findings: write-exclusion wrong (need resource allocation/partition-merge), missing macromolecular machinery (polymerization primitive), JAX+stiff ODEs not solved (need SciPy reference impl), 20-week timeline off by 5-10x, stochastic solver belongs in Phase 1, need pint for units, data versioning needed, M. genitalium UGA=Trp not stop codon
    - Both agreed: split deliverable into v1.0 (framework + toy cell) and v2.0 (M. genitalium)
    - Both agreed: AI panels should be evidence extractors, not decision-makers
    - Synthesized findings presented to user; asked if anything was missed before incorporating

15. User asked "are we missing any other findings?" — this is where compaction occurred
</history>

<work_done>
Files created/updated:
- E:\opencell\plan.md — Master plan document (~900 lines). Iteratively updated throughout session with 4 rounds of critique incorporated. Contains: vision, project structure, 6 phases, hardware profile, AI agent strategy, agent communication, conflict resolution, data contracts, orchestrator architecture, key technical decisions (expanded), biological sub-models, rejected alternatives (LangChain/LangGraph), mandatory policies, cross-model audit findings (Round 1), success criteria, 4 stretch goals, dev blog structure.
- C:\Users\sdrona\.copilot\session-state\5c51d44b-5a9f-4b23-85ff-0fddaadf2212\plan.md — Session copy, synced from E: drive version.
- E:\opencell\test_brenda.py — DELETED (cleaned up after testing)
- E:\opencell\test_brenda2.py — DELETED (cleaned up after testing)

SQL state:
- 68 todos in `todos` table (was rebuilt from scratch during this session)
- ~104 dependencies in `todo_deps` table
- All todos status: 'pending' (none started)
- First ready todo: `p1-repo-setup` (only task with no unmet dependencies)
- Also exists: `review_notes` table (mentioned in reminder but not created by us)

Work completed:
- [x] LangChain/LangGraph evaluation and rejection rationale
- [x] Incorporated Round 1 audit findings (Opus 4.6 + GPT-5.2) into plan
- [x] Added proactive safeguards (dep check, coupling benchmark, DB access in P1)
- [x] GitHub account decided (sdrona-ms, private until Phase 3)
- [x] Confidence assessment and bottleneck analysis
- [x] Database access research (BRENDA, KEGG, BioCyc, UniProt licensing)
- [x] BRENDA API test (failed — activation delay, will retry)
- [x] Added dev blog structure
- [x] Added cost_tracker.py to plan
- [x] Round 2 critique completed (GPT-5.4 + Opus 4.7)
- [x] Synthesized Round 2 findings for user
- [ ] Round 2 findings NOT YET incorporated into plan.md
- [ ] Implementation not started
</work_done>

<technical_details>
### Round 2 Critique Findings (NOT YET IN PLAN — must incorporate)

**BLOCKING issues from GPT-5.4 + Opus 4.7:**
1. **Write-exclusion is wrong** — ATP, ribosomes, tRNAs are written by multiple sub-models. Need resource allocation/partition-merge semantics (like Karr 2012), not write-exclusion.
2. **AI panels are NOT scientific decision-makers** — demote to evidence extractors + draft generators. Critical decisions need human approval + automated source verification (DOI exists + contains claimed value).
3. **No uncertainty/identifiability program** — parameters need distributions/ensembles, not just point values. Need structural/practical identifiability checks.
4. **Missing essential biology** — macromolecular machinery (polymerization primitive for RNAP elongation, ribosome footprints, replisome), DNA topology/supercoiling (acknowledged as scoped out).
5. **Validation anchored to Karr, not reality** — need orthogonal experimental data, split fit targets from held-out validation targets, define benchmark charter.

**HIGH issues:**
6. **Timeline: v1.0 = framework + toy cell (publishable). v2.0 = M. genitalium (separate project)**
7. **Add pint for unit handling at IR boundary from day 1**
8. **Promote environment/media to first-class runtime object**
9. **Move stochastic solver (tau-leaping) to Phase 1 alongside ODE solver**
10. **Add data versioning (DVC or content-hashed snapshots)** — database params change over time
11. **No thermodynamic feasibility checks** — reaction directionality, loopless FBA
12. **No observation model** — can't validate against experiments without mapping internal states → assay readouts
13. **FBA-ODE coupling needs concrete contract** — how often, what triggers, interpolation
14. **Build SciPy reference implementation alongside JAX** — escape hatch for stiff systems
15. **"Toy cell" is coupled-solver benchmark, not a biological cell** — frame honestly
16. **Temperature=0 may hurt literature search diversity** — make determinism task-specific
17. **M. genitalium uses UGA as tryptophan (not stop codon)** — translation model must handle
18. **Task numbering has duplicates (1.4, 1.5, 1.10 appear twice)** — fix in plan

**MEDIUM issues:**
- Identifier reconciliation (KEGG/BioCyc/UniProt crosswalk) is a hidden Phase 4 blocker
- Checkpoint exact-restart fragile across Diffrax versions — narrow claim
- Growth rate "within 2x" too loose — tighten to ±30% or acknowledge qualitative
- No regime-switch/failure-state modeling
- Operator splitting order-independence test may give false confidence
- State representation may explode at scale (complexes, promoter states, etc.)

### Key Architecture Decisions (Current)
- **Language**: Python 3.12
- **GPU**: None (Intel UHD 630), JAX CPU mode, Colab for heavy runs
- **Internal IR**: Typed canonical in-memory model (SBML is import/export)
- **Solver**: Diffrax (JAX) + SciPy fallback (to be added)
- **FBA**: Offline/episodic COBRApy, outside JAX inner loop
- **Hybrid coupling**: Operator splitting + sync points + mass-balance reconciliation
- **AI agents**: 6 roles, 4 tiers, custom orchestrator (rejected LangChain/LangGraph)
- **Agent temp**: 0 for all agents (may revise for literature search per Round 2)
- **Data format**: YAML params, HDF5 output/checkpoints, SBML interop
- **Packaging**: pyproject.toml, uv.lock, Apache 2.0
- **GitHub**: sdrona-ms/opencell (private until Phase 3)

### Database Access Status
- **BRENDA**: Registered (dronasrinivas@gmail.com), web portal works, SOAP API not yet working (activation delay). PASSWORD NEEDS CHANGING.
- **BioCyc**: Not yet accessed, needs subscription (~$100-150/yr) or institutional access
- **KEGG**: Free API (3 req/s), no redistribution allowed — use fetch scripts
- **UniProt/GenBank**: Free, open, no restrictions
- **Karr 2012**: Free on GitHub (~1,900 parameters) — primary fallback data source

### Environment
- OS: Windows 11 Enterprise Insider Preview (Build 26220)
- Machine: Lenovo 11EVS09B00, Intel i7-10700, 64GB RAM
- Python: 3.14.0 (primary) + 3.12 (use this for project, user confirmed)
- Git: 2.53.0, Node: 22.20.0
- Ollama: NOT installed yet
- GitHub CLI: NOT installed
- Domain: fareast.corp.microsoft.com (Microsoft corporate machine)
- Working drive: E: (~930GB free)

### Gotchas
- Python 3.14 is too new for JAX/COBRApy wheels — must use 3.12
- User requires named venvs when created
- Corporate SSL proxy causes certificate errors (workaround: verify=False for testing)
- PowerShell escaping issues with $ in strings — use script files or chr() workarounds
- User's BRENDA password was exposed in chat — must change it
</technical_details>

<important_files>
- E:\opencell\plan.md
   - The master plan document (~900 lines)
   - Contains everything: vision, structure, 6 phases (68 tasks), hardware, AI strategy, protocols, policies, audit findings, stretch goals
   - Round 2 critique findings (GPT-5.4 + Opus 4.7) are NOT YET incorporated — this is the immediate next step
   - Key sections: Project Structure (~line 25), Implementation Phases (~line 199), Hardware (~line 325), AI Strategy (~line 337), Agent Communication (~line 461), Conflict Resolution (~line 499), Data Contracts (~line 536), Orchestrator (~line 626), Technical Decisions (~line 690), Rejected Alternatives (~line 742), Mandatory Policies (~line 773), Audit Findings Round 1 (~line 806), Success Criteria (~line 848), Stretch Goals (~line 865)

- C:\Users\sdrona\.copilot\session-state\5c51d44b-5a9f-4b23-85ff-0fddaadf2212\plan.md
   - Session copy, must stay synced with E: drive version
</important_files>

<next_steps>
Immediate (before starting implementation):
1. **User asked "are we missing any other findings?"** — need to answer this, then incorporate Round 2 findings into plan.md. Key changes:
   - Replace write-exclusion with resource allocation/partition-merge
   - Demote AI panels from decision-makers to evidence extractors
   - Add uncertainty/identifiability as first-class concern
   - Add polymerization primitive, observation model, environment model
   - Split deliverable: v1.0 (framework + toy cell), v2.0 (M. genitalium)
   - Move stochastic solver to Phase 1
   - Add pint for units, DVC for data versioning
   - Add SciPy reference implementation alongside JAX
   - Fix task numbering duplicates
   - Add thermodynamic feasibility checks
   - Tighten growth rate criterion
   - Note M. genitalium UGA=Trp in translation model
   - Make temperature policy task-specific (not universal 0)
2. **Update SQL todos** to match revised plan
3. **BRENDA API** — retry later (activation delay)
4. **User needs to change BRENDA password**

When user says "start":
5. Begin p1-repo-setup — scaffold E:\opencell\ with full project structure
6. Create Python 3.12 named venv
7. Install GitHub CLI, authenticate as sdrona-ms
8. Dependency compatibility check (JAX, Diffrax, COBRApy on 3.12)

Blockers:
- Round 2 findings not yet incorporated
- User hasn't said "start" yet — still in planning/review phase
- Ollama not installed
- GitHub CLI not installed
- BRENDA API access not confirmed
</next_steps>